Clinical Trial Update: Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating memory-enriched T cells following stem cell transplantation for recurrent B-cell non-Hodgkin lymphomas; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Memory Enriched T Cells

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mantle Cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING